OTC ad spend in Australia will be 64% higher than it was in 2019, Zenith reports

Advertising expenditure by over-the-counter (OTC) healthcare brands in 13 key markets is predicted to expand by 7.6% in 2022 and 5.0% in 2023, according to Zenith’s new Business Intelligence – OTC Healthcare report, published today.

This growth, the report said, will be driven by tailored digital brand advertising, as well as performance advertising driving traffic to OTC ecommerce platforms.

Be a member to keep reading

Join Mumbrella Pro to access the Mumbrella archive and read our premium analysis of everything under the media and marketing umbrella.

Become a member

Get the latest media and marketing industry news (and views) direct to your inbox.

Sign up to the free Mumbrella newsletter now.

"*" indicates required fields

 

SUBSCRIBE

Sign up to our free daily update to get the latest in media and marketing.